medicase limited Company Information
Company Number
06678349
Website
www.medicase.co.ukRegistered Address
radnor house greenwood close, cardiff gate business park, cardiff, south glamorgan, CF23 8AA
Industry
General medical practice activities
Telephone
02920730811
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
joanna elizabeth longstaffe 34%
executors of admnistrators for the estate payne 34%
View Allmedicase limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICASE LIMITED at £2.8m based on a Turnover of £5.9m and 0.47x industry multiple (adjusted for size and gross margin).
medicase limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICASE LIMITED at £82.3k based on an EBITDA of £19.6k and a 4.21x industry multiple (adjusted for size and gross margin).
medicase limited Estimated Valuation
Pomanda estimates the enterprise value of MEDICASE LIMITED at £0 based on Net Assets of £-13.9k and 2.83x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medicase Limited Overview
Medicase Limited is a live company located in cardiff, CF23 8AA with a Companies House number of 06678349. It operates in the general medical practice activities sector, SIC Code 86210. Founded in August 2008, it's largest shareholder is joanna elizabeth longstaffe with a 34% stake. Medicase Limited is a established, mid sized company, Pomanda has estimated its turnover at £5.9m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Medicase Limited Health Check
Pomanda's financial health check has awarded Medicase Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
3 Strong
4 Regular
4 Weak
Size
annual sales of £5.9m, make it larger than the average company (£1.9m)
- Medicase Limited
£1.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (7%)
- Medicase Limited
7% - Industry AVG
Production
with a gross margin of 35.5%, this company has a comparable cost of product (35.5%)
- Medicase Limited
35.5% - Industry AVG
Profitability
an operating margin of 0.3% make it less profitable than the average company (3.4%)
- Medicase Limited
3.4% - Industry AVG
Employees
with 80 employees, this is above the industry average (24)
- Medicase Limited
24 - Industry AVG
Pay Structure
on an average salary of £30k, the company has an equivalent pay structure (£30k)
- Medicase Limited
£30k - Industry AVG
Efficiency
resulting in sales per employee of £73.9k, this is equally as efficient (£74.8k)
- Medicase Limited
£74.8k - Industry AVG
Debtor Days
it gets paid by customers after 42 days, this is near the average (38 days)
- Medicase Limited
38 days - Industry AVG
Creditor Days
its suppliers are paid after 55 days, this is slower than average (28 days)
- Medicase Limited
28 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Medicase Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (41 weeks)
3 weeks - Medicase Limited
41 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 101.7%, this is a higher level of debt than the average (62.1%)
101.7% - Medicase Limited
62.1% - Industry AVG
MEDICASE LIMITED financials
Medicase Limited's latest turnover from March 2023 is estimated at £5.9 million and the company has net assets of -£13.9 thousand. According to their latest financial statements, we estimate that Medicase Limited has 80 employees and maintains cash reserves of £57.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 5 | 5 | 4 | 4 | 3 | 5 | |||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 312 | 713 | 1,236 | 353 | 585 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 312 | 713 | 1,236 | 353 | 585 | 0 | 0 | 0 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 695,454 | 749,773 | 898,934 | 1,006,131 | 873,542 | 1,076,388 | 1,341,142 | 1,543,300 | 1,273,942 | 1,312,297 | 1,045,551 | 583,939 | 214,681 | 48,618 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 57,120 | 49,218 | 29,797 | 15,811 | 9,693 | 7,959 | 28,108 | 20,068 | 27,586 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 57,303 | 18,231 | 3,404 | 1,316 | 1,371 | 1,722 | 1,514 | 0 | 0 | 434 | 0 | 6,176 | 16,703 | 10,840 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 809,877 | 817,222 | 932,135 | 1,023,258 | 884,606 | 1,086,069 | 1,370,764 | 1,563,368 | 1,301,528 | 1,312,731 | 1,045,551 | 590,115 | 231,384 | 59,458 | 0 |
total assets | 809,877 | 817,222 | 932,135 | 1,023,258 | 884,606 | 1,086,069 | 1,370,764 | 1,563,680 | 1,302,241 | 1,313,967 | 1,045,904 | 590,700 | 231,384 | 59,458 | 0 |
Bank overdraft | 9,952 | 9,707 | 7,906 | 29,910 | 54,513 | 52,582 | 84,843 | 90,868 | 68,229 | 0 | 217 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 578,885 | 556,984 | 611,704 | 740,865 | 619,289 | 698,974 | 715,305 | 958,982 | 772,916 | 1,075,764 | 898,672 | 482,275 | 189,835 | 58,235 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 212,550 | 246,140 | 237,137 | 254,015 | 206,697 | 264,186 | 401,212 | 333,414 | 260,821 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 801,387 | 812,831 | 856,747 | 1,024,790 | 880,499 | 1,015,742 | 1,201,360 | 1,383,264 | 1,101,966 | 1,075,764 | 898,889 | 482,275 | 189,835 | 58,235 | 0 |
loans | 22,435 | 32,387 | 42,094 | 0 | 0 | 0 | 0 | 31,325 | 74,600 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117,875 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 22,435 | 32,387 | 42,094 | 0 | 0 | 0 | 0 | 31,325 | 74,600 | 117,875 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 823,822 | 845,218 | 898,841 | 1,024,790 | 880,499 | 1,015,742 | 1,201,360 | 1,414,589 | 1,176,566 | 1,193,639 | 898,889 | 482,275 | 189,835 | 58,235 | 0 |
net assets | -13,945 | -27,996 | 33,294 | -1,532 | 4,107 | 70,327 | 169,404 | 149,091 | 125,675 | 120,328 | 147,015 | 108,425 | 41,549 | 1,223 | 0 |
total shareholders funds | -13,945 | -27,996 | 33,294 | -1,532 | 4,107 | 70,327 | 169,404 | 149,091 | 125,675 | 120,328 | 147,015 | 108,425 | 41,549 | 1,223 | 0 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | Aug 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 312 | 401 | 523 | 332 | 232 | 118 | 0 | 0 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Tax | |||||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -46,417 | -129,740 | -93,211 | 138,707 | -201,112 | -284,903 | -194,118 | 261,840 | -10,769 | 266,746 | 461,612 | 369,258 | 166,063 | 48,618 | 0 |
Creditors | 21,901 | -54,720 | -129,161 | 121,576 | -79,685 | -16,331 | -243,677 | 186,066 | -302,848 | 177,092 | 416,397 | 292,440 | 131,600 | 58,235 | 0 |
Accruals and Deferred Income | -33,590 | 9,003 | -16,878 | 47,318 | -57,489 | -137,026 | 67,798 | 72,593 | 260,821 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | -9,952 | -9,707 | 42,094 | 0 | 0 | 0 | -31,325 | -43,275 | 74,600 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -117,875 | 117,875 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | 39,072 | 14,827 | 2,088 | -55 | -351 | 208 | 1,514 | 0 | -434 | 434 | -6,176 | -10,527 | 5,863 | 10,840 | 0 |
overdraft | 245 | 1,801 | -22,004 | -24,603 | 1,931 | -32,261 | -6,025 | 22,639 | 68,229 | -217 | 217 | 0 | 0 | 0 | 0 |
change in cash | 38,827 | 13,026 | 24,092 | 24,548 | -2,282 | 32,469 | 7,539 | -22,639 | -68,663 | 651 | -6,393 | -10,527 | 5,863 | 10,840 | 0 |
medicase limited Credit Report and Business Information
Medicase Limited Competitor Analysis
Perform a competitor analysis for medicase limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
medicase limited Ownership
MEDICASE LIMITED group structure
Medicase Limited has no subsidiary companies.
Ultimate parent company
MEDICASE LIMITED
06678349
medicase limited directors
Medicase Limited currently has 2 directors. The longest serving directors include Dr Joanna Longstaffe (Mar 2010) and Dr David Hughes (Mar 2010).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Joanna Longstaffe | United Kingdom | 59 years | Mar 2010 | - | Director |
Dr David Hughes | 69 years | Mar 2010 | - | Director |
P&L
March 2023turnover
5.9m
+46%
operating profit
19.6k
0%
gross margin
35.6%
-6.72%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
-13.9k
-0.5%
total assets
809.9k
-0.01%
cash
57.3k
+2.14%
net assets
Total assets minus all liabilities
medicase limited company details
company number
06678349
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
August 2008
age
16
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
radnor house greenwood close, cardiff gate business park, cardiff, south glamorgan, CF23 8AA
last accounts submitted
March 2023
medicase limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to medicase limited. Currently there are 1 open charges and 0 have been satisfied in the past.
medicase limited Companies House Filings - See Documents
date | description | view/download |
---|